Skip to content
Use caution Medical device recall · FDA · Published February 10, 2026

Medline Puracol Wound Dressings Recall: Elevated Endotoxin Risk

Medline recalls Puracol and Puracol Plus collagen wound dressings with elevated endotoxin levels that may cause inflammation, delayed healing, fever, or septic shock if used.

🇺🇸 FDA recall #Z-1650-2026Medical deviceMedline ›
Take action

Contact the company

Recalling firmMedline Industries, LP3 Lakes Dr · Northfield, IL 60093-2753
✎ GovInfoNow plain-language explainer

Medline is recalling Puracol and Puracol Plus collagen wound dressings due to elevated endotoxin levels in some lots. Using these dressings could cause local tissue irritation, delayed wound healing, fever, or even septic shock in severe cases. Read more at govinfonow.com/recall/50034-medline-puracol-wound-dressings-recall-elevated-endotoxin-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/50034-medline-puracol-wound-dressings-recall-elevated-endotoxin-risk · Updated August 10, 2026 · FDA enforcement record: FDA #Z-1650-2026

Cite this page

“Medline Puracol Wound Dressings Recall: Elevated Endotoxin Risk.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/50034-medline-puracol-wound-dressings-recall-elevated-endotoxin-risk. Based on FDA recall #Z-1650-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1650-2026%22&limit=1).

The FDA announced on Feb. 10, 2026, that Medline Industries, LP is recalling Puracol and Puracol Plus Collagen Wound Dressings due to elevated endotoxin levels. The agency stated the issue may elicit strong inflammatory responses if used.

How to tell if you have it

  • Brand: Medline
  • Product: Puracol and Puracol Plus Collagen Wound Dressings
  • Model/UPC: MSC8522 DRESSING,COLLAGEN,PURACOL,STRL,2" X 2" (UDI-DI 10080196285860 each, 40080196285861 case)
  • Model/UPC: MSC8622EP DRESSING,COLLAGEN,PURACOL PLUS, 2X2.2" (UDI-DI 10080196296804 each, 40080196296805 case)
  • Lot codes: P2090 and PL2107
  • Distribution: Nationwide US; Mexico and Panama

The hazard

According to the FDA, elevated endotoxin levels in the affected lots may elicit a strong inflammatory response if used. This can include local tissue irritation, delayed wound healing, or systemic effects such as fever and hypotension. In severe cases, septic shock may result.

Context

GovInfoNow's records show Medline Industries, LP has 68 other recalls on record since July 31, 2025. Other recent recalls of similar products include Medline Basic Homecare Beds and Medlite Homecare Beds (Aug. 14, 2026), Medline Convenience Kits (Aug. 11, 2026), and Medline convenience kits containing Healthmark Instrument Channel Brushes (Aug. 10, 2026).

How to tell if you have this one

Check for the model numbers MSC8522 (2" x 2") or MSC8622EP (2" x 2.2") on the packaging. Affected lots include P2090 for MSC8522 and PL2107 for MSC8622EP.

  • Brand
    Medline
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Dressing Model

    Identify the model number on the packaging to determine if it's affected (MSC8522 or MSC8622EP).

  2. Contact Medline

    Reach out to Medline for guidance on whether your dressing is affected and what to do next.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Domestic distribution nationwide US. International distribution to Mexico and Panama.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 50 days after the firm started it.

1. Firm started the recall: Feb 10, 202612. FDA classified it Class II: Mar 26, 202623. Published in FDA’s Enforcement Report: Apr 1, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1650-2026 (February 10, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1650-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA